Latest news with #BenHendrix
Business Insider
03-05-2025
- Business
- Business Insider
RBC Capital Sticks to Its Buy Rating for The Ensign Group (ENSG)
RBC Capital analyst Ben Hendrix maintained a Buy rating on The Ensign Group (ENSG – Research Report) on May 1 and set a price target of $177.00. The company's shares closed yesterday at $132.32. Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. According to TipRanks, Hendrix is a 3-star analyst with an average return of 1.7% and a 47.55% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Tenet Healthcare, Brookdale Senior Living, and Chemed. Currently, the analyst consensus on The Ensign Group is a Strong Buy with an average price target of $166.00. ENSG market cap is currently $7.37B and has a P/E ratio of 24.07.
Yahoo
15-02-2025
- Business
- Yahoo
CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm's price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the shares. The company is past its earnings trough with management setting 2025 guidance ahead of expectations while also expressing confidence in its long-term Medicare Advantage – MA – margin recovery, the analyst tells investors in a research note. The MA utilization appears to have stabilized, which, alongside disciplined pricing, could drive upside to consensus estimates in the out years, RBC adds. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CVS: CVS Health price target raised to $70 from $66 at Deutsche Bank CVS Health Corp's Mixed Earnings Call Highlights Growth and Challenges CVS Health price target raised to $76 from $60 at Truist Target downgraded, Cisco upgraded: Wall Street's top analyst calls CVS Health price target raised to $75 from $63 at BofA Sign in to access your portfolio
